Drug delivery refers to a process of delivering a drug into the patient’s body to have an effective therapeutic effect. Different modes are used for the delivery of drug. Nasal and pulmonary routes are most popular modes for delivering drug. The global drug delivery market is growing at a significant rate due to growing awareness in the field and technical innovations in the field. Intranasal drug delivery refers to a process of delivering the administered drug through nasal route. Drugs that are delivering through nasal means may be prescribed for acute or chronic treatments. Various types of drugs that are delivered through nasal cavity are local anesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, snuffs, antihistamines and others.
On the basis of the type of device, the global intranasal drug delivery market may be classified into nasal sprays, ointments and solutions. On the basis of therapeutic applications, the global intranasal drug delivery market can be classified into analgesic, allergic infections, pain management, osteoporosis, sexual dysfunction and vaccines. The global market for intranasal drug delivery is increasing at a significant rate due to increasing R&D in the field, high adoption rate for this delivery mode. Use of nasal cavity for delivering drug leads to increased efficacy of the drug. Intranasal drug delivery is also used for treatment of anxiety and depression.
North America dominates the global market for intranasal drug delivery due to increasing adoption of nasal mode for delivering of drug and improved healthcare facilities in the region. In addition, government initiatives and more awareness among the people are some of the major factors driving the intranasal drug delivery market. Asia, followed by Europe, is expected to experience high growth rate in the next few years in intranasal drug delivery market. China and India are expected to be the fastest growing intranasal drug delivery markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for intranasal drug delivery market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.
Some of the major factors driving the global intranasal drug delivery market are high prevalence of cardiovascular diseases, cancer and diabetes, rising demand for home healthcare devices and increased focus on pediatric and elderly patients. Some other factors driving the global intranasal drug delivery market are improvement in economy of emerging countries, improved healthcare infrastructure. In addition, improvement in the reimbursement scenario is driving the global market for intranasal drug delivery. However, high cost involved and lack of skilled medical professionals are some of the major factors restraining the global market for intranasal drug delivery.
Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for the global market for intranasal drug delivery. In addition, increasing R&D for rapid research and development of new drug delivery technologies and devices with better efficacy is expected to offer good opportunities for the global market for intranasal drug delivery. However, failure in drug formulation and technical barriers are some of the major challenge faced by the global market for intranasal drug delivery. One of the latest trends that have been observed in the global intranasal drug delivery market includes companies involved in product launches.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3631
Some of the major companies dealing in global intranasal drug delivery market are Aegis Therapeutics LLC, Alza Corporation, AstraZeneca PLC., MedImmune, Inc., Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline PLC and Johnson & Johnson, Inc. some other companies having significant presence in global intranasal drug delivery market are Marina Biotech, Inc., Merck & Co., Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc. and Rexam Plc.
Buy Now: You can now buy a single user license of the report at http://www.persistencemarketresearch.com/checkout/3631
The final report customized as per your specific requirement will be sent to your e-mail id within 7-20 days, depending on the scope of the report.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
For more information, please e-mail us at firstname.lastname@example.org